In a significant development a jury in California jury found Bayer’s Roundup weedkiller was not the cause of a woman’s non-Hodgkin’s lymphoma, said Bayer in a statement. The verdict marks the second such victory in court for the chemical giant… Read More ›
weedkiller
Bayer AG reaches $1.6 billion settlement agreement for U.S. lawsuits surrounding Essure birth control implantable device
German drugs and pesticides giant Bayer AG stated, it will pay around $1.6 billion to settle the majority of U.S. claims involving its Essure birth-control device. The agreement comes in the wake of a $10.9 billion settlement which it hammered… Read More ›
Bayer proposes to pay $8 billion to settle 18,000 U.S. lawsuits over Monsanto’s Roundup weedkiller
Bayer’s strategic could potentially significantly reduce headwinds revolving around lawsuits stemming from Monsanto’s glyphosate-based weedkiller – Roundup. On Friday, shares of Bayer surged by 11% following a report from Bloomberg that it has proposed to pay $8 billion in order… Read More ›
Bayer to invest $5.6 billion in new weed killer
It appears that Bayer intends on creating another line of weedkillers other than Monsanto’s RoundUp, which is causing it lots of grief stemming from thousands of U.S. lawsuits. RoundUp contains glyphosate, which according to plaintiffs, causes cancer. On Friday, in… Read More ›
Bayer hires law firm Sidley Austin for investigating pan-Europe influence scheme by Monsanto
Bayer has its hands full due to U.S. class-action lawsuits revolving around Monsanto’s Roundup weed killer which has glyphosate which causes cancer. In a statement, Bayer AG said it has hired Sidley Austin, a law firm to investigate a Europe-wide… Read More ›
Bayer faces strong legal headwinds, gains shareholders backing despite AGM rebuke
It would be interesting to see Bayer’s due diligence for its acquisition of Monsanto since even before Bayer’s $63 billion acquisition of Monsanto, the latter was facing lawsuits related to its Roundup weedkiller. According to two of Bayer’s largest German… Read More ›
Lawsuits from Monsanto’s weedkiller Roundup haunts Bayer
Bayer is likely to face negative investor sentiments on Friday at its AGM on the way its management team handled the $63 billion Monsanto deal. According to two sources familiar with the matter at hand, BlackRock will not support Bayer’s… Read More ›
California court rules Nufarm’s glyphosate-based herbicide caused cancer
Given the widespread usage of glyphosate in agriculture, no wonder investors are jittery. Although Bayer-owned Monsanto has stood by its stance that its herbicide is safe for human use, in practice taken steps to reduce concentration levels of the chemical… Read More ›